Sponsored by
It is a good start, especially the part about tracking treatments after approval, but if they were serious about finding the cure they would incorporate earlier approvals as outlined here. That would cut the time and costs by an order of magnitude.
[Editor's Note: It is a good start, especially the part about tracking treatments after approval, but if they were serious about finding the cure they would incorporate earlier approvals as outlined here. That would cut the time and costs by an order of magnitude. ]